Frontlight ResearchEarly access
CompletedNo phase
Genome-Wide Assocation Study in Patients With Brain Injury Associated Fatigue and Altered Cognition (BIAFAC)
Key facts
- Who runs it
- The University of Texas Medical Branch, Galveston
- Where
- Galveston, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 68 people enrolled
- Started
- 21 Jun 2021
- Ended
- 18 Jan 2024
- Type of study
- Observational
- Record updated
- 24 December 2025
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
The registry criteria, word for word
Show all 4 criteriaShow less
Who can take part
- History of TBI
- History of BIAFAC symptoms
- Ages 18 to 70 years
Who cannot take part
- Unable or unwilling to give written consent
Where in United States
- University of Texas Medical BranchGalveston, United States
About the trial
What the trial wants to find out
The aim of this study is elucidate genetic susceptibility of patients with traumatic brain injury (TBI) and symptoms of Brain Injury Associated Fatigue and Altered Cognition (BIAFAC) using genome-wide association study (GWAS).
The group in the trial
- TBI BIAFAC
100 TBI subjects with BIAFAC will be enrolled. No intervention
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Machine Learning Tools to Identify and Associate Genetic Variants in Patients With Phenotypic Traits of Brain Injury Associated Fatigue and Altered Cognition (BIAFAC)
- Record updated
- 24 December 2025